Class of Alzheimer's drug presents unique challenge for patients with cardiovascular disease retrieved 18 March 2024 from https://medicalxpress.com/news/2024-03-class-alzheimer-drug-unique-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s DiseasesNew collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions.
Source: NewsMedical - 🏆 19. / 71 Read more »
FDA delays decision on new Alzheimer's drugInstead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's maker said Friday.
Source: medical_xpress - 🏆 101. / 51 Read more »
Highly awaited Alzheimer's drug hit by delaysEli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Source: medical_xpress - 🏆 101. / 51 Read more »
Peter Andre's fears about growing older - 'Alzheimer's is really scary'EXCLUSIVE: In his weekly column, singer Peter Andre opened up on his fears about growing older, bidding a fond farewell to GB News and needing help with names for the new baby
Source: new_magazine - 🏆 72. / 59 Read more »
Nutrition's crucial role in Alzheimer's progression revealedStudy highlights the strong association between nutrition, particularly malnutrition, and the risk and progression of Alzheimer's disease, emphasizing early dietary interventions as key to reducing AD's global burden.
Source: NewsMedical - 🏆 19. / 71 Read more »
Wristwatch-like devices detect early signs of Alzheimer'sMonitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer's disease, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Source: NewsMedical - 🏆 19. / 71 Read more »